Considerations about COVID-19 vaccines in pregnant and nursing mothers

1Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Currently, there are vaccines with proven efficacy and safety in the mother-child binomial, such as the anti-influenza, anti-diphtheria, anti-tetanus, and acellular anti-pertussis vaccines. The most effective method in the control of epidemics and pandemics is vaccination, especially in priority groups that could have serious and complicated manifestations of the disease such as pregnant women. Currently, there are candidates for COVID-19 vaccines with different platforms: mRNA, non-replicative adenovirus vectors, DNA, inactivated whole virus, and protein subunits, among others. The Health Organization (WHO), the Centers for Disease Control (CDC), the American College of Obstetrics and Gynecology of the United States, and the National Academy of Medicine of Venezuela have pronounced on the subject and agree that pregnant and lactating women should be included in the priority group in the immunization plans of the countries, with the COVID-19 vaccines approved in that population group.

Author supplied keywords

Cite

CITATION STYLE

APA

de Carvajal, A. C. C. (2021, April 1). Considerations about COVID-19 vaccines in pregnant and nursing mothers. Gaceta Medica de Caracas. Academia Nacional de Medicina. https://doi.org/10.47307/GMC.2021.129.2.20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free